Stock Research for BSX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BSX Stock Chart & Research Data

The BSX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BSX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BSX Due diligence Resources & Stock Charts

The BSX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BSX Detailed Price Forecast - CNN Money CNN View BSX Detailed Summary - Google Finance
Yahoo View BSX Detailed Summary - Yahoo! Finance Zacks View BSX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BSX Trends & Analysis - Trade-Ideas Barrons View BSX Major Holders - Barrons
NASDAQ View BSX Call Transcripts - NASDAQ Seeking View BSX Breaking News & Analysis - Seeking Alpha
Spotlight View BSX Annual Report - CompanySpotlight.com OTC Report View BSX OTC Short Report - OTCShortReport.com
TradeKing View BSX Fundamentals - TradeKing Charts View BSX SEC Filings - Bar Chart
WSJ View Historical Prices for BSX - The WSJ Morningstar View Performance/Total Return for BSX - Morningstar
MarketWatch View the Analyst Estimates for BSX - MarketWatch CNBC View the Earnings History for BSX - CNBC
StockMarketWatch View the BSX Earnings - StockMarketWatch MacroAxis View BSX Buy or Sell Recommendations - MacroAxis
Bullish View the BSX Bullish Patterns - American Bulls Short Pains View BSX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BSX Stock Mentions - StockTwits PennyStocks View BSX Stock Mentions - PennyStockTweets
Twitter View BSX Stock Mentions - Twitter Invest Hub View BSX Investment Forum News - Investor Hub
Yahoo View BSX Stock Mentions - Yahoo! Message Board Seeking Alpha View BSX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BSX - SECform4.com Insider Cow View Insider Transactions for BSX - Insider Cow
CNBC View BSX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BSX - OTC Markets
Yahoo View Insider Transactions for BSX - Yahoo! Finance NASDAQ View Institutional Holdings for BSX - NASDAQ


Stock Charts

FinViz View BSX Stock Insight & Charts - FinViz.com StockCharts View BSX Investment Charts - StockCharts.com
BarChart View BSX Stock Overview & Charts - BarChart Trading View View BSX User Generated Charts - Trading View




Latest Financial News for BSX


Boston Scientific Eluvia Drug-Eluting Stent Demonstrates Superior Results In IMPERIAL Trial
Posted on Saturday September 22, 2018

SAN DIEGO and MARLBOROUGH, Mass., Sept. 22, 2018 /PRNewswire/ -- Today, Boston Scientific (BSX) announced positive 12-month data from the IMPERIAL trial, the first head-to-head drug-eluting stent trial in the superficial femoral artery (SFA). Results were presented during a late-breaking clinical trial session at the 30th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in San Diego, and at the annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress in Lisbon, Portugal. The clinical findings will be published in The Lancet.


Boston Scientific, Edwards Lifesciences May Tempt J&J
Posted on Friday September 21, 2018

Either device maker could be a rewarding acquisition for the old-line pharma and consumer-product company


Strong Buys on Netflix, Nvidia
Posted on Friday September 21, 2018

RESEARCH REPORTS These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or recommendations of Barron’s.


Is Abbott Laboratories Trading at a High Valuation in September?
Posted on Friday September 21, 2018

On September 19, Abbott Laboratories (ABT) was trading at a forward PE multiple of 21.8x, while its trailing-12-month PE multiple was 52.4x. Its forward PE and trailing-12-month PE multiples were 19.2x and 55.7x, respectively, a few months ago in May.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.